56 results
Page 2 of 3
6-K
EX-99.1
9f43r
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
ng63 gealhpk
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.2
s1hzpwa9 ja3oo
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
94vm1y5ez um9
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
e6u010d1wyj3kcjp
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.2
pasx7hm2a7ae2nol 3s
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
de98n9mrgqpt7
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.2
zdot9csxej37r4l1
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.1
83shhy8j
9 Dec 19
Galapagos completes recruitment of NOVESA trial in systemic sclerosis
10:11am
6-K
EX-99.2
mn0eltqde10evub3dhzq
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99
p3jljrpzq
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.2
2l3dfd9m
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm